Prefrontal executive function associated coupling relates to Huntington's disease stage

Cortex

Volumn 49, Issue 10, 2013, Pages 2661-2673

  Unschuld, Paul G ^a,d   Liu, Xinyang ^c   Shanahan, Megan ^a   Margolis, Russell L ^a   Bassett, Susan S ^a   Brandt, Jason ^a   Schretlen, David J ^a   Redgrave, Graham W ^a   Hua, Jun ^a,b   Hock, Christoph ^d   Reading, Sarah A ^a   van Zijl, Peter C M ^a,b   Pekar, James J ^a,b   Ross, Christopher A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Cognition; Cortical networks; Executive function; FMRI; Functional connectivity; Huntington's disease; Neurodegeneration

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ASSOCIATION CORTEX; BOLD SIGNAL; CAG REPEAT; CONTROLLED STUDY; CORRELATION ANALYSIS; EXECUTIVE FUNCTION; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENE MUTATION; GRAY MATTER; HUMAN; HUNTINGTON CHOREA; INSULA; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREFRONTAL CORTEX; PREMOTOR CORTEX; SOMATOSENSORY CORTEX; SUPRAMARGINAL GYRUS; TOWER OF LONDON TEST; VISUAL CORTEX;

COGNITION; CORTICAL NETWORKS; EXECUTIVE FUNCTION; FMRI; FUNCTIONAL CONNECTIVITY; HUNTINGTON'S DISEASE; NEURODEGENERATION;

ADULT; BRAIN MAPPING; DISEASE PROGRESSION; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE NET; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

EID: 84889684255     PISSN: 00109452     EISSN: 19738102     Source Type: Journal    
DOI: 10.1016/j.cortex.2013.05.015     Document Type: Article

References (104)

1. Alvarez J.A., Emory E. Executive function and the frontal lobes: A meta-analytic review. Neuropsychology Reviews 2006, 16(1):17-42.
2. Andrew S.E., Goldberg Y.P., Kremer B., Telenius H., Theilmann J., Adam S., et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genetics 1993, 4(4):398-403.
3. Aylward E., Mills J., Liu D., Nopoulos P., Ross C.A., Pierson R., et al. Association between age and striatal volume stratified by CAG repeat length in prodromal Huntington disease. PLoS Currents 2011, 3:RRN1235.
4. Aylward E.H. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease. Brain Research Bulletin 2007, 72(2-3):152-158.
5. Aylward E.H., Brandt J., Codori A.M., Mangus R.S., Barta P.E., Harris G.J. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology 1994, 44(5):823-828.
6. Aylward E.H., Codor A.M., Barta P.E., Pearlson G.D., Harris G.J., Brandt J. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Archives Neurology 1996, 53(12):1293-1296.
7. Aylward E.H., Codori A.M., Rosenblatt A., Sherr M., Brandt J., Stine O.C., et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Movement Disorders 2000, 15(3):552-560.
8. Aylward E.H., Li Q., Stine O.C., Ranen N., Sherr M., Barta P.E., et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 1997, 48(2):394-399.
9. Aylward E.H., Liu D., Nopoulos P.C., Ross C.A., Pierson R.K., Mills J.A., et al. Striatal volume contributes to the prediction of onset of Huntington disease in incident cases. Biological Psychiatry 2012, 71(9):822-828.
10. Aylward E.H., Nopoulos P.C., Ross C.A., Langbehn D.R., Pierson R.K., Mills J.A., et al. Longitudinal change in regional brain volumes in prodromal Huntington disease. Journal of Neurology, Neurosurgery & Psychiatry 2011, 82(4):405-410.
11. Baddeley A., Wilson B. Frontal amnesia and the dysexecutive syndrome. Brain and Cognition 1988, 7(2):212-230.
12. Badre D. Cognitive control, hierarchy, and the rostro-caudal organization of the frontal lobes. Trends in Cognitive Sciences 2008, 12(5):193-200.
13. Baker S.C., Rogers R.D., Owen A.M., Frith C.D., Dolan R.J., Frackowiak R.S., et al. Neural systems engaged by planning: A PET study of the Tower of London task. Neuropsychologia 1996, 34(6):515-526.
14. Beckmann C.F., DeLuca M., Devlin J.T., Smith S.M. Investigations into resting-state connectivity using independent component analysis. Philosophical Transactions of the Royal Society B: Biological Sciences 2005, 360(1457):1001-1013.
15. Behzadi Y., Restom K., Liau J., Liu T.T. A component based noise correction method (CompCor) for BOLD and perfusion based fMRI. NeuroImage 2007, 37(1):90-101.
16. Benedict R.H.B., Schretlen D.J., Groninger L., Dobraski M., Sphritz B. Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability and validity. Psychological Assessment 1996, 8:145-153.
17. Biglan K.M., Ross C.A., Langbehn D.R., Aylward E.H., Stout J.C., Queller S., et al. Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT-HD study. Movement Disorders 2009, 24(12):1763-1772.
18. Biswal B., Yetkin F.Z., Haughton V.M., Hyde J.S. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magnetic Resonance in Medicine 1995, 34(4):537-541.
19. Brandt J., Folstein S.E., Folstein M.F. Differential cognitive impairment in Alzheimer's disease and Huntington's disease. Annals of Neurology 1988, 23(6):555-561.
20. Brandt J., Inscore A.B., Ward J., Shpritz B., Rosenblatt A., Margolis R.L., et al. Neuropsychological deficits in Huntington's disease gene carriers and correlates of early "conversion". Journal of Neuropsychiatry and Clinical Neurosciences 2008, 20(4):466-472.
21. Brandt J., Shpritz B., Codori A.M., Margolis R., Rosenblatt A. Neuropsychological manifestations of the genetic mutation for Huntington's disease in presymptomatic individuals. Journal of the International Neuropsychological Society 2002, 8(7):918-924.
22. Bright P., Jaldow E., Kopelman M.D. The National Adult Reading Test as a measure of premorbid intelligence: A comparison with estimates derived from demographic variables. Journal of the International Neuropsychological Society 2002, 8(6):847-854.
23. Brown J.W. Medial prefrontal cortex activity correlates with time-on-task: What does this tell us about theories of cognitive control?. NeuroImage 2011, 57(2):314-315.
24. Buckner R.L., Andrews-Hanna J.R., Schacter D.L. The brain's default network: Anatomy, function, and relevance to disease. Annals of the New York Academy of Sciences 2008, 1124:1-38.
25. Calhoun V.D., Adali T., Pearlson G.D., Pekar J.J. A method for making group inferences from functional MRI data using independent component analysis. Human Brain Mapping 2001, 14(3):140-151.
26. Castellanos F.X., Margulies D.S., Kelly C., Uddin L.Q., Ghaffari M., Kirsch A., et al. Cingulate-precuneus interactions: A new locus of dysfunction in adult attention-deficit/hyperactivity disorder. Biological Psychiatry 2008, 63(3):332-337.
27. Chai X.J., Castanon A.N., Ongur D., Whitfield-Gabrieli S. Anticorrelations in resting state networks without global signal regression. NeuroImage 2012, 59(2):1420-1428.
28. Chai X.J., Whitfield-Gabrieli S., Shinn A.K., Gabrieli J.D., Nieto Castanon A., McCarthy J.M., et al. Abnormal medial prefrontal cortex resting-state connectivity in bipolar disorder and schizophrenia. Neuropsychopharmacology 2011, 36(10):2009-2017.
29. Cohen A.L., Fair D.A., Dosenbach N.U., Miezin F.M., Dierker D., Van Essen D.C., et al. Defining functional areas in individual human brains using resting functional connectivity MRI. NeuroImage 2008, 41(1):45-57.
30. Dagher A., Owen A.M., Boecker H., Brooks D.J. Mapping the network for planning: A correlational PET activation study with the Tower of London task. Brain 1999, 122(Pt 10):1973-1987.
31. Di Martino A., Scheres A., Margulies D.S., Kelly A.M., Uddin L.Q., Shehzad Z., et al. Functional connectivity of human striatum: A resting state FMRI study. Cerebral Cortex 2008, 18(12):2735-2747.
32. Duff K., Paulsen J., Mills J., Beglinger L.J., Moser D.J., Smith M.M., et al. Mild cognitive impairment in prediagnosed Huntington disease. Neurology 2010, 75(6):500-507.
33. Duff K., Paulsen J.S., Beglinger L.J., Langbehn D.R., Stout J.C. Psychiatric symptoms in Huntington's disease before diagnosis: The predict-HD study. Biological Psychiatry 2007, 62(12):1341-1346.
34. Duyao M., Ambrose C., Myers R., Novelletto A., Persichetti F., Frontali M., et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genetics 1993, 4(4):387-392.
35. Edwards A.L. An Introduction to Linear Regression and Correlation 1984, W.H. Freeman & Co., New York, NY, Illustrated. 2nd ed.
36. Fellows L.K. Advances in understanding ventromedial prefrontal function: The accountant joins the executive. Neurology 2007, 68(13):991-995.
37. Fingelkurts A.A., Kahkonen S. Functional connectivity in the brain - is it an elusive concept?. Neuroscience & Biobehavioral Reviews 2005, 28(8):827-836.
38. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., et al. Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33(3):341-355.
39. Fischl B., Salat D.H., van der Kouwe A.J., Makris N., Segonne F., Quinn B.T., et al. Sequence-independent segmentation of magnetic resonance images. NeuroImage 2004, 23(Suppl. 1):S69-S84.
40. Fisher A.O. Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika 1915, 10(4):522-529.
41. Folstein S.E., Jensen B., Leigh R.J., Folstein M.F. The measurement of abnormal movement: Methods developed for Huntington's disease. Neurobehavioral Toxicology and Teratology 1983, 5(6):605-609.
42. Fox M.D., Snyder A.Z., Vincent J.L., Corbetta M., Van Essen D.C., Raichle M.E. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proceedings of the National Academy of Sciences 2005, 102(27):9673-9678.
43. Friston K.J. Commentary and opinion: II. Statistical parametric mapping: Ontology and current issues. Journal of Cerebral Blood Flow & Metabolism 1995, 15(3):361-370.
44. Friston K.J., Frith C.D., Liddle P.F., Frackowiak R.S. Functional connectivity: The principal-component analysis of large (PET) data sets. Journal of Cerebral Blood Flow & Metabolism 1993, 13(1):5-14.
45. Goldberg T.E., Weinberger D.R. Genes and the parsing of cognitive processes. Trends in Cognitive Sciences 2004, 8(7):325-335.
46. Greicius M.D., Flores B.H., Menon V., Glover G.H., Solvason H.B., Kenna H., et al. Resting-state functional connectivity in major depression: Abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological Psychiatry 2007, 62(5):429-437.
47. Greicius M.D., Krasnow B., Reiss A.L., Menon V. Functional connectivity in the resting brain: A network analysis of the default mode hypothesis. Proceedings of the National Academy of Sciences 2003, 100(1):253-258.
48. Gusella J.F., Wexler N.S., Conneally P.M., Naylor S.L., Anderson M.A., Tanzi R.E., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983, 306(5940):234-238.
49. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993, 72(6):971-983. HD_Collaborative_Research_Group.
50. Holm S. A simple sequentially rejective Bonferroni test procedure. Scandinavian Journal of Statistics 1979, 6:65-70.
51. Holtzheimer P.E., Kelley M.E., Gross R.E., Filkowski M.M., Garlow S.J., Barrocas A., et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Archives of General Psychiatry 2012, 69(2):150-158.
52. Joel S.E., Caffo B.S., van Zijl P.C., Pekar J.J. On the relationship between seed-based and ICA-based measures of functional connectivity. Magnetic Resonance in Medicine 2011, 66(3):644-657.
53. Klöppel S., Draganski B., Siebner H.R., Tabrizi S.J., Weiller C., Frackowiak R.S. Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain 2009, 132(Pt 6):1624-1632.
54. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., Hayden M.R. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics 2004, 65(4):267-277.
55. Lawrence A.D., Sahakian B.J., Hodges J.R., Rosser A.E., Lange K.W., Robbins T.W. Executive and mnemonic functions in early Huntington's disease. Brain 1996, 119(Pt 5):1633-1645.
56. Leh S.E., Petrides M., Strafella A.P. The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology 2010, 35(1):70-85.
57. Mahant N., McCusker E.A., Byth K., Graham S. Huntington's disease: Clinical correlates of disability and progression. Neurology 2003, 61(8):1085-1092.
58. Margulies D.S., Kelly A.M., Uddin L.Q., Biswal B.B., Castellanos F.X., Milham M.P. Mapping the functional connectivity of anterior cingulate cortex. NeuroImage 2007, 37(2):579-588.
59. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin 2003, 65:193-207.
60. Morris R.G., Ahmed S., Syed G.M., Toone B.K. Neural correlates of planning ability: Frontal lobe activation during the Tower of London test. Neuropsychologia 1993, 31(12):1367-1378.
61. Mostofsky S.H., Powell S.K., Simmonds D.J., Goldberg M.C., Caffo B., Pekar J.J. Decreased connectivity and cerebellar activity in autism during motor task performance. Brain 2009, 132(Pt 9):2413-2425.
62. Newman S.D., Carpenter P.A., Varma S., Just M.A. Frontal and parietal participation in problem solving in the Tower of London: fMRI and computational modeling of planning and high-level perception. Neuropsychologia 2003, 41(12):1668-1682.
63. Paulsen J.S. Functional imaging in Huntington's disease. Experimental Neurology 2009, 216(2):272-277.
64. Paulsen J.S. Cognitive impairment in Huntington disease: Diagnosis and treatment. Current Neurology and Neuroscience Reports 2011, 11:474-483.
65. Paulsen J.S., Langbehn D.R., Stout J.C., Aylward E., Ross C.A., Nance M., et al. Detection of Huntington's disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry 2008, 79(8):874-880.
66. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., et al. Brain structure in preclinical Huntington's disease. Biological Psychiatry 2006, 59(1):57-63.
67. Paulsen J.S., Nopoulos P.C., Aylward E., Ross C.A., Johnson H., Magnotta V.A., et al. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Research Bulletin 2010, 82(3-4):201-207.
68. Penney J.B., Vonsattel J.P., MacDonald M.E., Gusella J.F., Myers R.H. CAG repeat number governs the development rate of pathology in Huntington's disease. Annals of Neurology 1997, 41(5):689-692.
69. Phillips L.H., Wynn V., Gilhooly K.J., Della Sala S., Logie R.H. The role of memory in the Tower of London task. Memory 1999, 7(2):209-231.
70. Reading S.A., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., et al. Functional brain changes in presymptomatic Huntington's disease. Annals of Neurology 2004, 55(6):879-883.
71. Rosas H.D., Feigin A.S., Hersch S.M. Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. NeuroRx: The Journal of the American Society for Experimental NeuroTherapeutics 2004, 1(2):263-272.
72. Rosas H.D., Goodman J., Chen Y.I., Jenkins B.G., Kennedy D.N., Makris N., et al. Striatal volume loss in HD as measured by MRI and the influence of CAG repeat. Neurology 2001, 57(6):1025-1028.
73. Rosas H.D., Koroshetz W.J., Chen Y.I., Skeuse C., Vangel M., Cudkowicz M.E., et al. Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis. Neurology 2003, 60(10):1615-1620.
74. Rosas H.D., Salat D.H., Lee S.Y., Zaleta A.K., Pappu V., Fischl B., et al. Cerebral cortex and the clinical expression of Huntington's disease: Complexity and heterogeneity. Brain 2008, 131(Pt 4):1057-1068.
75. Rosenblatt A., Abbott M.H., Gourley L.M., Troncoso J.C., Margolis R.L., Brandt J., et al. Predictors of neuropathological severity in 100 patients with Huntington's disease. Annals of Neurology 2003, 54(4):488-493.
76. Rosenblatt A., Kumar B.V., Margolis R.L., Welsh C.S., Ross C.A. Factors contributing to institutionalization in patients with Huntington's disease. Movement Disorders 2011, 26(9):1711-1716.
77. Rosenblatt A., Kumar B.V., Mo A., Welsh C.S., Margolis R.L., Ross C.A. Age, CAG repeat length, and clinical progression in Huntington's disease. Movement Disorders 2012, 27(2):272-276.
78. Rosenblatt A., Liang K.Y., Zhou H., Abbott M.H., Gourley L.M., Margolis R.L., et al. The association of CAG repeat length with clinical progression in Huntington disease. Neurology 2006, 66(7):1016-1020.
79. Rosenblatt A., Margolis R.L., Becher M.W., Aylward E., Franz M.L., Sherr M., et al. Does CAG repeat number predict the rate of pathological changes in Huntington's disease?. Annals of Neurology 1998, 44(4):708-709.
80. Ross C.A., Tabrizi S.J. Huntington's disease: From molecular pathogenesis to clinical treatment. Lancet Neurology 2011, 10(1):83-98.
81. Roy A.K., Shehzad Z., Margulies D.S., Kelly A.M., Uddin L.Q., Gotimer K., et al. Functional connectivity of the human amygdala using resting state fMRI. NeuroImage 2009, 45(2):614-626.
82. Seber G.A.F. Multivariate Observations 1984, John Wiley & Sons, Inc., Hoboken, NJ.
83. Shallice T. Specific impairments of planning. Philosophical Transactions of the Royal Society B: Biological Sciences 1982, 298(1089):199-209.
84. Späth H. Cluster Dissection and Analysis: Theory, FORTRAN Programs, Examples 1985, Halsted Press, New York, NY.
85. Stevens M.C., Pearlson G.D., Calhoun V.D. Changes in the interaction of resting-state neural networks from adolescence to adulthood. Human Brain Mapping 2009, 30(8):2356-2366.
86. Sturrock A., Laule C., Decolongon J., Dar Santos R., Coleman A.J., Creighton S., et al. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology 2010, 75(19):1702-1710.
87. Tabrizi S.J., Reilmann R., Roos R.A., Durr A., Leavitt B., Owen G., et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: Analysis of 24 month observational data. Lancet Neurology 2012, 11(1):42-53.
88. Uddin L.Q., Supekar K., Amin H., Rykhlevskaia E., Nguyen D.A., Greicius M.D., et al. Dissociable connectivity within human angular gyrus and intraparietal sulcus: Evidence from functional and structural connectivity. Cerebral Cortex 2010, 20(11):2636-2646.
89. Unschuld P.G., Edden R.A., Carass A., Liu X., Shanahan M., Wang X., et al. Brain metabolite alterations and cognitive dysfunction in early Huntington's disease. Movement Disorders 2012, 27(7):895-902.
90. Unschuld P.G., Joel S.E., Liu X., Shanahan M., Margolis R.L., Biglan K.M., et al. Impaired cortico-striatal functional connectivity in prodromal Huntington's disease. Neuroscience Letters 2012, 514(2):204-209.
91. van de Ven V.G., Formisano E., Prvulovic D., Roeder C.H., Linden D.E. Functional connectivity as revealed by spatial independent component analysis of fMRI measurements during rest. Human Brain Mapping 2004, 22(3):165-178.
92. van den Bogaard S., Dumas E., van der Grond J., van Buchem M., Roos R. MRI biomarkers in Huntington's disease. Frontiers in Bioscience (Elite Edition) 2012, 4:1910-1925.
93. Van Dijk K.R., Hedden T., Venkataraman A., Evans K.C., Lazar S.W., Buckner R.L. Intrinsic functional connectivity as a tool for human connectomics: Theory, properties, and optimization. Journal of Neurophysiology 2010, 103(1):297-321.
94. Vannorsdall T.D., Schretlen D.J., Andrejczuk M., Ledoux K., Bosley L.V., Weaver J.R., et al. Altering automatic verbal processes with transcranial direct current stimulation. Frontiers in Psychiatry/Frontiers Research Foundation 2012, 3:73.
95. Watkins L.H., Rogers R.D., Lawrence A.D., Sahakian B.J., Rosser A.E., Robbins T.W. Impaired planning but intact decision making in early Huntington's disease: Implications for specific fronto-striatal pathology. Neuropsychologia 2000, 38(8):1112-1125.
96. Whitfield-Gabrieli S., Nieto-Castanon A. Conn: A functional connectivity toolbox for correlated and anticorrelated brain networks. Brain Connectivity 2012, 2(3):125-141.
97. Whitfield-Gabrieli S., Thermenos H.W., Milanovic S., Tsuang M.T., Faraone S.V., McCarley R.W., et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proceedings of the National Academy of Sciences 2009, 106(4):1279-1284.
98. Wilk S.S. Certain generalizations in the analysis of variance. Biometrika 1932, 24(3-4):498-510.
99. Wolf R.C., Gron G., Sambataro F., Vasic N., Wolf N.D., Thomann P.A., et al. Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness. Human Brain Mapping 2012, 33(9):2161-2173.
100. Wolf R.C., Sambataro F., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer B. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Experimental Neurology 2008, 213(1):137-144.
101. Wolf R.C., Sambataro F., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer B. Altered frontostriatal coupling in pre-manifest Huntington's disease: Effects of increasing cognitive load. European Journal of Neurology 2008, 15(11):1180-1190.
102. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer G.B. Cortical dysfunction in patients with Huntington's disease during working memory performance. Human Brain Mapping 2009, 30(1):327-339.
103. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Landwehrmeyer G.B., Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: Evidence from event-related fMRI. Brain 2007, 130(Pt 11):2845-2857.
104. Declaration of Helsinki. Law, Medicine & Health Care 1991, 19(3-4):264-265. World_Medical_Association.